Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy

American Journal of Surgery

Volumn 185, Issue 6, 2003, Pages 525-531

  McIntosh, Stuart A ^a   Ogston, Keith N ^a   Payne, Simon ^a   Miller, Ian D ^a   Sarkar, Tarun K ^a   Hutcheon, Andrew W ^a   Heys, Steven D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Breast cancer; Primary chemotherapy; Recurrence

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; AXILLA; BREAST CARCINOMA; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PREDICTION; PRIORITY JOURNAL;

EID: 0038697392     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(03)00078-3     Document Type: Article

References (34)

1. Arnold D.J., Lesnick G.J. Survival following mastectomy for stage III breast cancer. Am J Surg. 137:1979;362-366.
2. Bonadonna G., Veronesi U., Brambilla C., et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst. 82:1990;1539-1545.
3. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 16:1998;2672-2685.
4. Jacquillat C., Weil M., Baillet F., et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast- conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer. 66:1990;119-129.
5. Morrow M., Braverman A., Thelmo W., et al. Multimodal therapy for locally advanced breast cancer. Arch Surg. 121:1986;1291-1296.
6. Hortobagyi G.N., Ames F.C., Buzdar A.U., et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 62:1988;2507-2516.
7. Loprinzi C.L., Carbone P.P., Tormey D.C., et al. Aggressive combined modality therapy for advanced local-regional breast carcinoma. J Clin Oncol. 2:1984;157-163.
8. Schwartz G.F., Cantor R.I., Biermann W.A. Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast. Arch Surg. 122:1987;1430-1434.
9. Hobar P.C., Jones R.C., Schouten J., et al. Multimodality treatment of locally advanced breast carcinoma. Arch Surg. 123:1988;951-955.
10. Luboinski G., Nagadowska M., Pienkowski T. Preoperative chemotherapy in primarily inoperable cancer of the breast. Eur J Surg Oncol. 17:1991;603-607.
11. Piccart M.J., de Valeriola D., Paridaens R., et al. Six-year results of a multimodality treatment strategy for locally advanced breast cancer. Cancer. 62:1988;2501-2506.
12. Heys S.D., Sarkar T.K., Ah-See A.K., et al. Multimodality treatment in the management of locally advanced breast cancer. J R Coll Surg Edinb. 38:1993;9-15.
13. Swain S.M., Sorace R.A., Bagley C.S., et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res. 47:1987;3889-3894.
14. Gazet J.C., Coombes R.C., Ford H.T., et al. Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. Br J Cancer. 73:1996;758-762.
15. Hutcheon A.W., Heys S.D., Miller I.D., et al. Improvements in survival in patients receiving primary chemotherapy with docetaxol for breast cancer a randomised controlled trial . Breast Cancer Res Treat. 69:2001;298.
16. Morrell L.E., Lee Y.J., Hurley J., et al. A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma. Cancer. 82:1998;503-511.
17. Braud A.C., Asselain B., Scholl S., et al. Neoadjuvant chemotherapy in young breast cancer patients correlation between response and relapse? Eur J Cancer. 35:1999;392-397.
18. Brain E., Garrino C., Misset J.L., et al. Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. Br J Cancer. 75:1997;1360-1367.
19. Scholl S.M., Pierga J.Y., Asselain B., et al. Breast tumor response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer. 31A:1995;1969-1975.
20. Mauriac L., MacGrogan G., Avril A., et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS) . Ann Oncol. 10:1999;47-52.
21. Buchholz T.A., Tucker S.L., Masullo L., et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol. 20:2002;17-23.
22. Steele R.J.C., Forrest A.P.M., Gibson T., et al. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer a controlled randomised trial . Br J Surg. 72:1985;368-369.
23. Chetty U., Jack W., Prescott R.J., et al. Management of the axilla in operable breast cancer treated by breast conservation a randomized clinical trial. Edinburgh Breast Unit . Br J Surg. 87:2000;163-169.
24. Heys S.D., Eremin J.M., Sarkar T.K., et al. Role of multimodality therapy in the management of locally advanced carcinoma of the breast. J Am Coll Surg. 179:1994;493-504.
25. Ogston K.N., Miller I., Payne S., et al. A novel grading system to assess pathological response and predict survival in patients receiving primary chemotherapy for breast cancer. Eur J Cancer. 37:(suppl 5):2001;27.
26. Fisher B., Anderson S., Fisher E.R., et al. Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet. 338:1991;327-331.
27. Whelan T., Clark R., Roberts R., et al. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality results from a randomized trial. Investigators of the Ontario Clinical Oncology Group . Int J Radiat Oncol Biol Phys. 30:1994;11-16.
28. Veronesi U., Marubini E., Del Vecchio M., et al. Local recurrences and distant metastases after conservative breast cancer treatments partly independent events . J Natl Cancer Inst. 87:1995;19-27.
29. Liljegren G., Holmberg L., Adami H.O., et al. Sector resection with or without postoperative radiotherapy for stage I breast cancer five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group . J Natl Cancer Inst. 86:1994;717-722.
30. Macmillan R.D., Purushotham A.D., George W.D. Local recurrence after breast-conserving surgery for breast cancer. Br J Surg. 83:1996;149-155.
31. Fisher B., Wolmark N., Bauer M., et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet. 152:1981;765-772.
32. Carter C.L., Allen C., Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 63:1989;181-187.
33. Fisher B., Bauer M., Wickerham D.L., et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 52:1983;1551-1557.
34. George M.L., Hale P.C., Gumpert J.R., et al. The use of neoadjuvant CMF to avoid mastectomy. Eur J Surg Oncol. 25:1999;50-53.